Antimicrobial Susceptibility and Clinical Sources of Dolosigranulum pigrum Cultures | Zendy

Leslye LaClaire | Zendy; Richard R. Facklam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial Susceptibility and Clinical Sources of Dolosigranulum pigrum Cultures

Author(s) -

Leslye LaClaire,

Richard R. Facklam

Publication year - 2000

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.44.7.2001-2003.2000

Subject(s) - cefotaxime , microbiology and biotechnology , erythromycin , cefuroxime , penicillin , quinupristin , levofloxacin , meropenem , antimicrobial , clindamycin , trimethoprim , dalfopristin , vancomycin , biology , antibiotics , antibiotic resistance , bacteria , genetics , staphylococcus aureus

Antimicrobial susceptibilities of 27 clinical isolates of Dolosigranulum pigrum were determined. All were susceptible to amoxicillin, cefotaxime, cefuroxime, clindamycin, levofloxacin, meropenem, penicillin, quinupristin-dalfopristin, rifampin, tetracycline, and vancomycin. Fifteen of the isolates were intermediate to chloramphenicol. One isolate was resistant to trimethoprim-sulfamethoxazole. Two isolates were susceptible, 10 were intermediate, and 15 were resistant to erythromycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research